Alvogen’s sister company, Alvotech, is a fully integrated specialty biopharmaceutical company focused exclusively on development and manufacturing of high-quality biosimilar medicines. They are specialists in biopharmaceutical product creation, all along the value chain from cell line development to commercial manufacturing.
Alvotech is uniquely positioned with a fully integrated R&D and manufacturing engine, driven by best-in-class in-house research and development. Its state-of-the-art manufacturing facility fill finish capacity, situated in a patent-friendly location in Reykjavik, Iceland. Mark Levick leads the Alvotech team with over 400 colleagues who are passionate about transforming patients’ lives and bringing high-quality biopharmaceuticals to market.